Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06623370
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-30
Brief Title:
The Effect of Methylprednisolone Administration on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effect of Methylprednisolone Administration on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to thoroughly investigate the interaction between methylprednisolone and sugammadex in the pediatric patient population Our hypothesis is that methylprednisolone will interact with sugammadex leading to a prolonged reversal time of rocuronium by sugammadex and at the same time a reduction in the effect profile of methylprednisolone
Approximately 80 volunteers will be included in the study Patients will not have any additional responsibilities related to this study There are no risks or benefits to patients associated with this research The study will begin immediately before the patients surgery and will end two hours after the operation Volunteers participating in the study will be randomly assigned to one of two groups one group will receive methylprednisolone during surgery and the other group will not Methylprednisolone is a medication used to prevent postoperative pain swelling nausea and vomiting If these complaints are detected in patients from either group after surgery appropriate treatments will be administered to alleviate them
Approximately 80 volunteers will be included in the study Patients will not have any additional responsibilities related to this study There are no risks or benefits to patients associated with this research The study will begin immediately before the patients surgery and will end two hours after the operation Volunteers participating in the study will be randomly assigned to one of two groups one group will receive methylprednisolone during surgery and the other group will not Methylprednisolone is a medication used to prevent postoperative pain swelling nausea and vomiting If these complaints are detected in patients from either group after surgery appropriate treatments will be administered to alleviate them
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None